mecamylamine has been researched along with Dystonic Disorders in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
Dystonic Disorders: Acquired and inherited conditions that feature DYSTONIA as a primary manifestation of disease. These disorders are generally divided into generalized dystonias (e.g., dystonia musculorum deformans) and focal dystonias (e.g., writer's cramp). They are also classified by patterns of inheritance and by age of onset.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Kutschenko, A | 1 |
Staege, S | 1 |
Grütz, K | 1 |
Glaß, H | 1 |
Kalmbach, N | 1 |
Gschwendtberger, T | 1 |
Henkel, LM | 1 |
Heine, J | 1 |
Grünewald, A | 1 |
Hermann, A | 1 |
Seibler, P | 1 |
Wegner, F | 1 |
1 other study available for mecamylamine and Dystonic Disorders
Article | Year |
---|---|
Functional and Molecular Properties of DYT-SGCE Myoclonus-Dystonia Patient-Derived Striatal Medium Spiny Neurons.
Topics: Acetylcholine; Action Potentials; Adult; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium | 2021 |